HRT Financial’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-81,927
Closed -$260K 2448
2025
Q1
$260K Buy
81,927
+65,539
+400% +$208K ﹤0.01% 1643
2024
Q4
$87K Buy
+16,388
New +$87K ﹤0.01% 1843
2023
Q4
Sell
-13,050
Closed -$19K 2239
2023
Q3
$19K Buy
+13,050
New +$19K ﹤0.01% 1853
2021
Q4
Sell
-30,769
Closed -$148K 3015
2021
Q3
$148K Buy
+30,769
New +$148K ﹤0.01% 2518